1. Home
  2. ENOV vs UVV Comparison

ENOV vs UVV Comparison

Compare ENOV & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • UVV
  • Stock Information
  • Founded
  • ENOV 1995
  • UVV 1886
  • Country
  • ENOV United States
  • UVV United States
  • Employees
  • ENOV N/A
  • UVV N/A
  • Industry
  • ENOV Fluid Controls
  • UVV Farming/Seeds/Milling
  • Sector
  • ENOV Industrials
  • UVV Industrials
  • Exchange
  • ENOV Nasdaq
  • UVV Nasdaq
  • Market Cap
  • ENOV 1.6B
  • UVV 1.3B
  • IPO Year
  • ENOV 2008
  • UVV N/A
  • Fundamental
  • Price
  • ENOV $32.14
  • UVV $55.50
  • Analyst Decision
  • ENOV Strong Buy
  • UVV
  • Analyst Count
  • ENOV 6
  • UVV 0
  • Target Price
  • ENOV $51.00
  • UVV N/A
  • AVG Volume (30 Days)
  • ENOV 1.0M
  • UVV 220.9K
  • Earning Date
  • ENOV 11-05-2025
  • UVV 08-06-2025
  • Dividend Yield
  • ENOV N/A
  • UVV 5.91%
  • EPS Growth
  • ENOV N/A
  • UVV N/A
  • EPS
  • ENOV N/A
  • UVV 4.11
  • Revenue
  • ENOV $2,189,576,000.00
  • UVV $2,943,996,000.00
  • Revenue This Year
  • ENOV $9.13
  • UVV $1.52
  • Revenue Next Year
  • ENOV $6.39
  • UVV $0.97
  • P/E Ratio
  • ENOV N/A
  • UVV $13.51
  • Revenue Growth
  • ENOV 14.40
  • UVV 4.11
  • 52 Week Low
  • ENOV $25.47
  • UVV $49.40
  • 52 Week High
  • ENOV $49.83
  • UVV $67.33
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 62.91
  • UVV 52.52
  • Support Level
  • ENOV $30.00
  • UVV $54.26
  • Resistance Level
  • ENOV $31.76
  • UVV $55.62
  • Average True Range (ATR)
  • ENOV 1.04
  • UVV 0.97
  • MACD
  • ENOV 0.21
  • UVV 0.12
  • Stochastic Oscillator
  • ENOV 82.68
  • UVV 58.14

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

Share on Social Networks: